📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme. (2023)

First Author: Dougados M

Attributed to: The 'CARDIOvascular-Immune-Mediated Inflammatory Diseases (CARDIO-IMID) UK Network' funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/ard-2022-223406

PubMed Identifier: 36720582

Publication URI: http://europepmc.org/abstract/MED/36720582

Type: Journal Article/Review

Volume: 82

Parent Publication: Annals of the rheumatic diseases

Issue: 4

ISSN: 0003-4967